BNR - Burning Rock Biotech Ltd
Burning Rock Biotech Ltd Logo

BNR - Burning Rock Biotech Ltd

https://www.brbiotech.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Burning Rock Biotech Limited primarily develops and provides screening tests for cancer therapies in the People's Republic of China. The company is headquartered in Guangzhou, China.

52W High
$11.12
52W Low
$2.18
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.92
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.17
EV/Revenue (<3 favorable)
0.35
P/S (TTM) (<3 favorable)
0.17
P/B (<3 favorable)
1.12
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
3.92%
Institutions (25–75% balanced)
51.46%
Shares Outstanding
9,034,100
Float
48,308,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
523,281,000
Gross Profit (TTM)
374,107,000
EPS (TTM)
-3.23
Profit Margin (>10% good)
-0.46%
Operating Margin (TTM) (higher better)
-0.11%
ROE (TTM) (>15% strong)
-0.37%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.06
Momentum
Bearish momentum
Value
0.6088
Previous
0.6447
Trend
Falling
Signal Cross
No cross
As of
Sep. 11, 2025